Last reviewed · How we verify
Generator-produced 99mTc
At a glance
| Generic name | Generator-produced 99mTc |
|---|---|
| Sponsor | British Columbia Cancer Agency |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients (NA)
- To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer (PHASE1)
- Sodium Pertechnetate (99Tc) Injection Generator: 99mTc From Neutron-activation 99Mo v 99mTc From Fission 99Mo (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Generator-produced 99mTc CI brief — competitive landscape report
- Generator-produced 99mTc updates RSS · CI watch RSS
- British Columbia Cancer Agency portfolio CI